Skip to main content
. 2011 Jan-Mar;18(1):42–47. doi: 10.4103/0974-9233.75884

Figure 1.

Figure 1

A 62-year-old man with active Graves’ ophthalmopathy before (top) and after (bottom) steroid treatment and bilateral upper eyelid botulinum toxin injection